Search results
Results from the WOW.Com Content Network
On Thursday, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported third-quarter adjusted EPS of $12.46, up 8% year-over-year, beating the consensus of $11.69. The company reported sales of $3.72 ...
Price Action: REGN shares closed at $1,050.86 on Thursday. "ACTIVE INVESTORS' SECRET WEAPON" Supercharge Your Stock Market Game with the #1 "news & everything else" trading tool: Benzinga Pro ...
In the latest trading session, Regeneron (REGN) closed at $747.33, marking a +1.38% move from the previous day.
Regeneron (REGN) closed the most recent trading day at $735.96, moving -0.01% from the previous trading session.
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York.The company was founded in 1988. [2] Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company branched out into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a ...
Regeneron (REGN) closed at $594.90 in the latest trading session, marking a -0.28% move from the prior day.
In the latest trading session, Regeneron (REGN) closed at $630.31, marking a -1.13% move from the previous day.
Regeneron Pharmaceuticals (REGN) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes. Regeneron Pharmaceuticals (REGN) Jumps: Stock Rises 6.3% Skip to main ...